| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |